Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/08/1996US5563153 Gel consists of tetracaine hydrochloride, epinephrine hydrochloride, coacaine hydrochloride and absorbable gelatin sterile powder
10/08/1996US5563151 Platelet activating factor receptor antagonists; antiinflammatory agents, analgesics
10/08/1996US5563146 Administering rapamycin
10/08/1996US5563145 Rapamycin 42-oximes and hydroxylamines
10/08/1996US5563144 Antiserotonins, their preparation and pharmaceutical compositions containing them
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/08/1996US5563141 Heterocyclic compounds
10/08/1996US5563140 Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives for the preparation of neuroprotective compositions
10/08/1996US5563139 Method of using 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of a glaucoma disorder
10/08/1996US5563138 Benzoheterocyclic compounds
10/08/1996US5563136 3-Ureidobenzodiazepinones useful as antagonists of CCK or of gastrin
10/08/1996US5563135 Immunosuppressive agent
10/08/1996US5563134 Pharmaceutical compositions comprising clozapine and a radical scavenger
10/08/1996US5563131 Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
10/08/1996US5563130 Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
10/08/1996US5563126 Determining levels of homocysteine, cystathionine, and or 2-methylcitric acid
10/08/1996US5563125 5'-deoxy-5'-(substituted)alkylthioribose compounds and their pharmaceutical compositions
10/08/1996US5563124 Osteogenic product and process
10/08/1996US5563121 Phosphinate methylene ammonium linkage
10/08/1996US5563054 Culturing streptomyces in nutrient medium
10/08/1996US5563050 Herpes virus
10/08/1996US5563049 Culture product
10/08/1996US5563044 Process for the enzymatic preparation of GRF(1-44)NH2
10/08/1996US5562923 Micronized pharmaceutically inhalable substances
10/08/1996US5562917 Includes water soluble methyl cellulose-type gel, and water
10/08/1996US5562913 Formulation for use in smokers
10/08/1996US5562910 Vaccine compositions and method for enhancing an immune response
10/08/1996US5562908 Treatment of sinus headache
10/08/1996CA2093048C Benzo¢b!thiophen-5-yl derivative and process for producing the same
10/08/1996CA2072460C Use of acid derivatives for pediculicidal medicament production
10/08/1996CA2051697C Heterocyclic amines having central nervous system activity
10/08/1996CA2010768C Acidic polycyclic ether antibiotic
10/08/1996CA1338637C Process for the preparation of new derivative of dihydro-1,4 pyridine and pharmaceutical compositions containing them
10/07/1996CA2173270A1 Enantiomerically-enhanced nutritional energy substrates
10/06/1996CA2173047A1 Retinoid-like heterocycles
10/04/1996CA2173305A1 Pyrazolidine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
10/03/1996WO1996030766A1 Inhibition of tau-tau-association
10/03/1996WO1996030505A1 Methods for screening compounds for estrogenic activity
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030403A1 Methods of treating disorders of the eye
10/03/1996WO1996030395A2 Cysteine protease inhibitor
10/03/1996WO1996030382A1 Maltitol composition and method for preparing same
10/03/1996WO1996030381A1 Immunosuppressive agents
10/03/1996WO1996030377A1 Nitrogenous macrocyclic compounds
10/03/1996WO1996030375A1 Process and crystal forms of 2-methyl-thieno-benzodiazepine
10/03/1996WO1996030374A1 Process for preparing olanzapine
10/03/1996WO1996030369A1 Process for the synthesis of nucleoside analogues
10/03/1996WO1996030366A1 Polymorphs a and b of 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl) propyl]piperazine
10/03/1996WO1996030365A1 Radiosensitizing diamines and their pharmaceutical preparations
10/03/1996WO1996030364A1 Pharmaceutical compositions
10/03/1996WO1996030363A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030362A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030358A1 Phenyl derivatives useful as endothelin receptor antagonists
10/03/1996WO1996030356A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
10/03/1996WO1996030355A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
10/03/1996WO1996030353A1 Reversible protease inhibitors
10/03/1996WO1996030350A1 Amidine derivatives
10/03/1996WO1996030348A1 Synthesis of bis-indolylmaleimides
10/03/1996WO1996030347A1 Quinazoline derivatives
10/03/1996WO1996030343A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030339A1 Pyrrolidinyl hydroxamic acid compounds and their production process
10/03/1996WO1996030333A1 Bicyclic amine derivatives and their use as anti-psychotic agents
10/03/1996WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/03/1996WO1996030328A1 Terminal carboxy or tetrazole groups containing dialkyl ethers
10/03/1996WO1996030326A1 Differentiating agents for the treatment of inflammatory intestinal diseases
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030036A1 Compounds and compositions for delivering active agents
10/03/1996WO1996030035A1 β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS
10/03/1996WO1996030034A1 Production of rhein and rhein derivatives
10/03/1996WO1996030033A1 Method of treating or preventing non-viral microbial infection
10/03/1996WO1996030028A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
10/03/1996WO1996030027A1 Inhibition of rotavirus infection with carrageenan or dextran sulfate
10/03/1996WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
10/03/1996WO1996030024A1 The pharmaceutical composition containing the 1,3,2-oxazaphosphorinane and mesna for the cancer treatment
10/03/1996WO1996030023A1 19-oxygenated steroids as therapeutic agents
10/03/1996WO1996030022A1 Topical ophthalmic formulations comprising an acidic drug, vitamin e tpgs, benzalkonium chloride and caffeine
10/03/1996WO1996030021A1 Azathioprine compositions for colonic administration
10/03/1996WO1996030020A1 Transdermal device for the delivery of alfuzosin
10/03/1996WO1996030019A1 Drug containing methotrexate derivative
10/03/1996WO1996030018A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030017A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030016A2 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
10/03/1996WO1996030015A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030014A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030013A1 Transmucosal delivery of melatonin for prevention of migraine
10/03/1996WO1996030012A1 Methods for treating conditions associated with excess nitric oxide
10/03/1996WO1996030011A1 Topical antimycotic compositions
10/03/1996WO1996030010A2 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
10/03/1996WO1996030009A2 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid
10/03/1996WO1996030008A1 Lidocaine-vasoconstrictor aerosol preparation
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996WO1996030005A1 Anti-stroke effects of calcium antagonists
10/03/1996WO1996030004A1 Inhibitors of metazoan parasite proteases
10/03/1996WO1996030003A1 Medicaments for the selective treatment of tumour tissues
10/03/1996WO1996030001A1 Method of making a pressure sensitive skin adhesive sheet material
10/03/1996WO1996030000A1 Pharmaceutical composition for transdermic delivery
10/03/1996WO1996029999A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
10/03/1996WO1996029997A1 Soft gelatin capsule with a gelatin shell comprising xanthine derivative
10/03/1996WO1996029995A1 Oral 2-methyl-thieno-benzodiazepine formulation
10/03/1996WO1996029992A1 Diltiazem controlled release formulation
1 ... 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 ... 7860